Summary papers

Head MG, Fitchett JR, Nageshwaran V, Kumari N, Hayward AC, Atun R. Research investments in global health: a systematic analysis of UK infectious disease research funding and global health metrics, 1997-2013. EBioMedicine. 2015. doi:10.1016/j.ebiom.2015.12.016

Head MG, Fitchett JR, Cooke MK, Wurie FB, Hayward AC, Atun R; UK investments in global infectious disease research 1997-2010: a case study. Lancet Infectious Diseases. 2013 Jan;13(1):55-64. doi: 10.1016/S1473-3099(12)70261-X

2016

Fitchett JR, Atun R. Innovative financing for late-stage global health research and development: the Global Health Investment Fund. International Health. 2016. 8 1): 3-4. doi: 10.1093/inthealth/ihv067

Head MG, Fitchett JR, Lichtman AB, Soyode DT, Harris JN, Atun R; Mapping investments and published outputs in Norovirus research: a systematic analysis of US and UK research 1997-2013. Journal of Infectious Diseases. 2016. 2016. 213: S3-S7 doi:10.1093/infdis/jiv366

2015

Fitchett JR, Atun R. Antimicrobial resistance: opportunity for Europe to establish global leadership. The Lancet Infectious Diseases. December 2015. doi:10.1016/S1473-3099(15)00410-7

Head MG, Fitchett JR, Derrick G, Wurie FB, Meldrum J, Kumari N, Beattie B, Counts CJ, Atun R. Comparing research investment to UK institutions and published outputs for tuberculosis, HIV and malaria: a systematic analysis across 1997-2013. Health Research Policy and Systems.2015, 13:63. DOI: 10.1186/s12961-015-0052-5
this manuscript is part of the WHO R&D Observatory call for evidence 

Seale AC, Head MG, Fitchett E, Vergnano S, Saha S, Heath P, Sharland M, Lawn JE, on behalf of SPRING. Neonatal infection: a major burden with minimal funding. Lancet Global Health. November 2015:11.e669–e670, DOI 10.1016/S2214-109X(15)00204-1

Head MG, Fitchett JR, Cassell JA, Atun R. Investments in sexually transmitted infection research, 1997–2013: a systematic analysis of funding awarded to UK institutions. Journal of Global Health. August 2015. 5: 020405.

Head MG, Fitchett JR, Newell ML, Scott AG, Harris JN, Clarke SC*, Atun R*. Mapping inequities surrounding pneumonia research: a systematic analysis of UK investments and published
outputs 1997-2013. EBioMedicine (July 2015). http://dx.doi.org/10.1016/j.ebiom.2015.06.024.
* Joint senior author
(Also see the linked commentary piece also published alongside this paper)

Head MG, Fitchett JR, Moore DAJ, Atun R; Systematic analysis of funding awarded to institutions in the United Kingdom for infectious disease research, 1997-2010. JRSM Open March 2015 vol. 6 no. 3. doi:2054270415577056

2014

Head MG, Fitchett JR, Newell ML, Scott AG, Clarke SC*, Atun R*; Investing in pneumonia and pneumococcal research. The Lancet Infectious Diseases. 2014.  Volume 14, Issue 11, Pages 1037 – 1038, November 2014. doi:10.1016/S1473-3099(14)70949-1
* Joint senior author

Fitchett JR, Head MG, Atun R; Investing in sepsis research: systematic analysis of UK public and philanthropic funding 1997–2010. JRSM Open. September 2014. Volume 5. doi: 10.1177/2054270414538954

Fitchett JR, Head MG, Cooke MK, Wurie FB, Atun R. Funding Infectious Disease Research: A Systematic Analysis of UK Research Investments by Funders 1997–2010. PLOS One. August 2014. DOI: 10.1371/journal.pone.0105722

Head MG, Fitchett JR, Cooke GS, Foster GR, Atun R; Systematic analysis of funding awarded for viral hepatitis-related research to institutions in the United Kingdom, 1997-2010 – Journal of Viral Hepatitis. August 2014. DOI: 10.1111/jvh.12300

Head MG. Gross underinvestment in antibacterial research. The Lancet Infectious DIseases. 2014 July. doi:10.1016/S1473-3099(14)70848-5

Head MG, Fitchett JR, Holmes AC, Atun R. Funding healthcare-associated infection research: a systematic analysis of UK research investments, 1997–2010. Journal of Hospital Infection.2014 June. 87:2.84-91. dx.doi.org/10.1016/j.jhin.2014.03.008

Head MG, Fitchett JR, Cooke MK, Wurie FB, Hayward AC, Lipman ML, Atun R; Investments in respiratory infectious disease research 1997–2010: a systematic analysis of UK funding. BMJ Open 2014;4:e004600 doi:10.1136/bmjopen-2013-004600

Fitchett JR, Head MG, Atun R; Infectious disease research investments follow colonial ties: questionable ethics. International Health. January 23, 2014. doi:10.1093/inthealth/iht036

Head MG, Fitchett JR, Atun R; Investing in antimicrobial resistance research. British Journal of Hospital Medicine, Vol. 75, Iss. 1, 08 Jan 2014, pp 6 – 7.

Head MG, Fitchett JR, Atun R, May RC; Systematic analysis of funding awarded for mycology research to institutions in the UK, 1997–2010. BMJ Open 2014;4:e004129 doi:10.1136/bmjopen-2013-004129

Head MG, Fitchett JR, Cooke MK, Wurie FB, Atun R, Hayward AC, Holmes A, Johnson AP, Woodford N; Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997-2010. Journal of Antimicrobial Chemotherapy 2014 Feb;69(2):548-54. doi: 10.1093/jac/dkt349 (first published online Sept 2013)

2013

Head MG, Fitchett JR, Cooke MK, Wurie FB, Atun R. Differences in research funding for women scientists: a comparison analysis of UK investments in global infectious disease research 1997–2010. BMJ Open 2013;3:e003362. doi:10.1136/bmjopen-2013-003362

Head MG, Fitchett JR, Atun R; Systematic analysis of funding awarded for norovirus research to institutions in the United Kingdom, 1997-2010; Journal of Royal Society of Medicine. 2013. doi: 10.1177/0141076813511450

Fitchett JR, Head MG, Atun R; Infectious disease research investments: Systematic analysis of immunology and vaccine research funding in the UK. Vaccine. Volume 31, Issue 50, December 2013, 5930-3

Head MG, Fitchett JR, Cooke MK, Wurie FB, Hayward AC, Atun R; UK investments in global infectious disease research 1997-2010: a case study; Lancet Infectious Diseases. 2013 Jan;13(1):55-64. doi: 10.1016/S1473-3099(12)70261-X
(Also see the linked commentary piece also published alongside this paper)

Correspondence pieces

Head MG, Fitchett JR, Clarke SC. Challenges in mapping research investments for treatments against pneumonia. Lancet Infectious Diseases. 2015. Volume 15. No. 11, p1262. DOI: /10.1016/S1473-3099(15)00351-5

Fitchett JR, Regmi S. Investment in antibiotics against pneumonia. The Lancet Infectious Diseases. Volume 15, No. 4, p376–377, April 2015. http://dx.doi.org/10.1016/S1473-3099(15)70082-4.

Head MG, Fitchett JR, Cooke MK, Wurie FB, Atun R. Sex discrepancies in infectious disease research funding 1997—2010: a systematic analysis. The Lancet, Volume 382, Page S44, 29 November 2013. doi:10.1016/S0140-6736(13)62469-1

Fitchett JR, Head MG, Atun R; The need for more investment in tuberculosis research. The Lancet Global Health. 10/2013; 1(4):e186. The Lancet Global Health, Volume 1, Issue 4, Page e186, October 2013. doi:10.1016/S2214-109X(13)70087-1

Head MG, Fitchett JR, Atun R; Global health priorities and research funding – Authors’ reply. The Lancet Infectious Diseases, Volume 13, Issue 8, Page 653, August 2013. doi:10.1016/S1473-3099(13)70169-5.

Published conference presentations

B. Sullivan, A. Bhatt, F. Huang, R. Atun, M. Maruthappu, J. Fitchett, M. Head. US and UK investments in global oncology research: A systematic analysis. Annals of Global Health. 2015. Volume 81, Issue 1, Page 214. DOI: http://dx.doi.org/10.1016/j.aogh.2015.02.991

JR Fitchett, M Head, R Atun, M Cooke, F Wurie. Funding infectious disease research: A systematic analysis of UK investments by funders 1997-2010. International Journal of Infectious Diseases. April 2014. 21:396.

JR Fitchett, M Head, D Heymann, R Atun. Investing in emerging infectious diseases: A systematic analysis of UK research. International Journal of Infectious Diseases. April 2014. 21:232.